Genomic Health, Inc. operates in the Medical laboratories sector. Genomic Health, Inc. (Genomic Health) is a molecular diagnostics company focused on the development and global commercialization of genomic-based clinical laboratory services , which analyzes the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The Company's Oncotype DX platform utilizes genomic analysis in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. It offers the Oncotype DX breast cancer test as a clinical service, where it analyzes the expression levels of 21 genes in tumor tissue samples and provides physicians with a gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score. The test also provides measurements of quantitative gene expression for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), genes, which are used in the calculation of the Recurrence Score result. In our complete report available for purchase the company is compared to: Medtox Scientific, Inc., Enzo Biochem, Inc. and Bio-Reference Laboratories, Inc..